80 FR 13251 - Medicare Program; Quality Incentive Program; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services

Federal Register Volume 80, Issue 49 (March 13, 2015)

This document corrects technical errors that appeared in the final rule published in the Federal Register on November 6, 2014 entitled ``End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies.''

[Federal Register Volume 80, Number 49 (Friday, March 13, 2015)]
[Rules and Regulations]
[Pages 13251-13252]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-05766]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

42 CFR Parts 405, 411, 413 and 414

[CMS-1614-CN]
RIN 0938-AS13


Medicare Program; Quality Incentive Program; Correction

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Final rule; correction.

-----------------------------------------------------------------------

SUMMARY: This document corrects technical errors that appeared in the 
final rule published in the Federal Register on November 6, 2014 
entitled ``End-Stage Renal Disease Prospective Payment System, Quality 
Incentive Program, and Durable Medical Equipment, Prosthetics, 
Orthotics, and Supplies.''

DATES: This correction is effective on March 13, 2015.

FOR FURTHER INFORMATION CONTACT: Tamyra Garcia, (410) 786-0856.

SUPPLEMENTARY INFORMATION:

I. Background

    In FR Doc. 2014-26182 of November 6, 2014 (79 FR 66120), there were 
technical and typographical errors that are identified and corrected in 
the Correction of Errors section below. The provisions in this 
correction document are effective as if they had been included in the 
document published on November 6, 2014. Accordingly, the corrections 
are effective March 13, 2015.

II. Summary of Errors

    On page 66184 of the preamble, we have determined that there were 
errors in the performance standard, achievement threshold, and 
benchmark values presented in the Numerical Values for the Performance 
Standards for the Payment Year (PY) 2017 End-Stage Renal Disease (ESRD) 
Quality Incentive Program (QIP) Clinical Measures Using the Most 
Recently Available Data table for PY 2017 of the ESRD QIP (Table 23). 
Specifically, the numerical values published for the Standardized 
Readmission Ratio clinical measure were calculated using only 6 months 
of data from calendar year 2013 instead of the full 12 months, as 
specified under our finalized policy (79 FR 66183). Therefore, we are 
publishing this technical correction to ensure that these numerical 
standards align with the finalized policies for the PY 2017 ESRD QIP.

III. Waiver of Proposed Rulemaking

    We ordinarily publish a notice of proposed rulemaking in the 
Federal Register to provide a period for public comment before the 
provisions of a rule take effect in accordance with section 553(b) of 
the Administrative Procedure Act (APA) (5 U.S.C. 553(b)). However, we 
can waive this notice and comment procedure if the Secretary finds, for 
good cause, that the notice and comment process is impracticable, 
unnecessary, or contrary to the public interest, and incorporates a 
statement of the finding and the reasons; therefore, in the notice.
    Since this rule correction is simply correcting technical and 
typographical errors in the preamble, but does not make substantive 
changes to the policies or payment methodologies that were adopted in 
the final rule, it is unnecessary to follow the notice and comment 
procedure in this instance. Therefore, we believe that we have good 
cause to forego notice and a period for comment.

IV. Correction of Errors

    In FR Doc. 2014-26182 of November 6, 2014 (79 FR 66120) make the 
following corrections:
    1. On page 66184, in Table 23 ``Numerical Values for the 
Performance Standards for the PY 2017 ESRD QIP Clinical Measures Using 
the Most

[[Page 13252]]

Recently Available Data''; in the fifth row titled ``Standardized 
Readmission Ratio'' remove the existing values and add the following 
values in their place:

----------------------------------------------------------------------------------------------------------------
                                                                 Performance      Achievement
                           Measure                                 standard        threshold        Benchmark
----------------------------------------------------------------------------------------------------------------
Standardized Readmission Ratio...............................           0.648            1.261            0.998
----------------------------------------------------------------------------------------------------------------


    Dated: March 6, 2015.
C'Reda Weeden,
Executive Secretary to the Department, Department of Health and Human 
Services.
[FR Doc. 2015-05766 Filed 3-12-15; 8:45 am]
 BILLING CODE 4120-01-P